This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

This study has been completed.
Omnicare Clinical Research
Information provided by (Responsible Party):
Peplin Identifier:
First received: October 14, 2007
Last updated: March 13, 2015
Last verified: March 2015
The purpose of this study is to examine the safety and toleration of PEP005 Topical Gel, administered on an actinic keratosis (AK) treatment area on the top of a hand.

Condition Intervention Phase
Actinic Keratosis Drug: PEP005 gel Phase 2

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Multi-center, Open-label Study to Examine the Safety and Toleration of 0.05% PEP005 Topical Gel in Patients With Actinic Keratoses on the Dorsum of the Hand

Resource links provided by NLM:

Further study details as provided by Peplin:

Primary Outcome Measures:
  • Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs); and Local Skin Responses (LSR) [ Time Frame: 57 days ]

Secondary Outcome Measures:
  • The complete clearance rate of AK lesions; partial clearance rate of AK lesions and baseline clearance rate of AK lesions. [ Time Frame: 57 days ]

Enrollment: 12
Study Start Date: October 2007
Study Completion Date: January 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: PEP005 gel administration
0.05% PEP005 Topical Gel administered for two consecutive days to a 25cm2 contiguous AK treatment area on the top of the hand
Drug: PEP005 gel
Two day application, 0.05%
Other Name: PEP005

Detailed Description:
Actinic keratoses (AK) is a common skin condition characterized by rough, scaly patches or sores on the top layer of the skin which if left untreated can progress to skin cancer. Current treatments can cause scarring and hypopigmentation, be inconvenient, or require long treatment duration. Non-invasive alternative therapy for treatment of AK lesions is thus being researched.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Male patients at least 18 years of age.
  • Post-menopausal female patients
  • 4 to 8 clinically typical, visible and discrete AK lesions within an area on the dorsum of one hand.
  • Written informed consent has been obtained.
  • Agreement from the patient to allow photographs of the selected AK treatment area to be taken and used as part of the study data package.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00544297

United States, California
Skin Surgery Medical Group Inc
San Diego, California, United States, 92117
United States, Georgia
Gwinnett Clinical Research Centre
Snellville, Georgia, United States, 30078-3250
United States, Texas
Dermatology Clinical Research Centre of San Antonio
San Antonio, Texas, United States, 78229-3409
Dermatology Associates of Tyler
Tyler, Texas, United States, 75703
Sponsors and Collaborators
Omnicare Clinical Research
Study Director: Arthur P Bertolino, MD Chief Medical Officer and VP Medical Affairs
  More Information

Additional Information:
Responsible Party: Peplin Identifier: NCT00544297     History of Changes
Other Study ID Numbers: PEP005-018
Study First Received: October 14, 2007
Last Updated: March 13, 2015

Keywords provided by Peplin:
Actinic Keratosis

Additional relevant MeSH terms:
Keratosis, Actinic
Skin Diseases
Precancerous Conditions
Neoplasms processed this record on June 22, 2017